Synopsis
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Bioplus Life Sciences
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Neelkanth MineChem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Direct Compression
Thickeners and Stabilizers
Disintegrants & Superdisintegrants
Granulation
Co-Processed Excipients
Lubricants & Glidants
Taste Masking
Chewable & Orodispersible Aids
Topical
Controlled & Modified Release
Coating Systems & Additives
Parenteral
Film Formers & Plasticizers
API Stability Enhancers
Emulsifying Agents
Solubilizers
Rheology Modifiers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
41
PharmaCompass offers a list of Cyproheptadine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cyproheptadine Hydrochloride manufacturer or Cyproheptadine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cyproheptadine Hydrochloride manufacturer or Cyproheptadine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Cyproheptadine Hydrochloride API Price utilized in the formulation of products. Cyproheptadine Hydrochloride API Price is not always fixed or binding as the Cyproheptadine Hydrochloride Price is obtained through a variety of data sources. The Cyproheptadine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cyproheptadine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cyproheptadine Hydrochloride, including repackagers and relabelers. The FDA regulates Cyproheptadine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cyproheptadine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cyproheptadine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cyproheptadine Hydrochloride supplier is an individual or a company that provides Cyproheptadine Hydrochloride active pharmaceutical ingredient (API) or Cyproheptadine Hydrochloride finished formulations upon request. The Cyproheptadine Hydrochloride suppliers may include Cyproheptadine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Cyproheptadine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cyproheptadine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Cyproheptadine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Cyproheptadine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Cyproheptadine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cyproheptadine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Cyproheptadine Hydrochloride USDMF includes data on Cyproheptadine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cyproheptadine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cyproheptadine Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cyproheptadine Hydrochloride Drug Master File in Japan (Cyproheptadine Hydrochloride JDMF) empowers Cyproheptadine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cyproheptadine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Cyproheptadine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cyproheptadine Hydrochloride suppliers with JDMF on PharmaCompass.
A Cyproheptadine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Cyproheptadine Hydrochloride Certificate of Suitability (COS). The purpose of a Cyproheptadine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cyproheptadine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cyproheptadine Hydrochloride to their clients by showing that a Cyproheptadine Hydrochloride CEP has been issued for it. The manufacturer submits a Cyproheptadine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cyproheptadine Hydrochloride CEP holder for the record. Additionally, the data presented in the Cyproheptadine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cyproheptadine Hydrochloride DMF.
A Cyproheptadine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cyproheptadine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cyproheptadine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Cyproheptadine Hydrochloride written confirmation (Cyproheptadine Hydrochloride WC) is an official document issued by a regulatory agency to a Cyproheptadine Hydrochloride manufacturer, verifying that the manufacturing facility of a Cyproheptadine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cyproheptadine Hydrochloride APIs or Cyproheptadine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Cyproheptadine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Cyproheptadine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cyproheptadine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cyproheptadine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cyproheptadine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cyproheptadine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cyproheptadine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cyproheptadine Hydrochloride suppliers with NDC on PharmaCompass.
Cyproheptadine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cyproheptadine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cyproheptadine Hydrochloride GMP manufacturer or Cyproheptadine Hydrochloride GMP API supplier for your needs.
A Cyproheptadine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Cyproheptadine Hydrochloride's compliance with Cyproheptadine Hydrochloride specifications and serves as a tool for batch-level quality control.
Cyproheptadine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Cyproheptadine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cyproheptadine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Cyproheptadine Hydrochloride EP), Cyproheptadine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cyproheptadine Hydrochloride USP).
